Initial Evaluation of Dihydroartemisinin (DHA), Metformin and Taro Extract in Combination with Cisplatin for Enhanced Cytotoxicity in Triple-Negative Breast Cancer (TNBC) Cell Lines
- DOI
- 10.30683/1927-7229.2026.15.06
- Published
- 2026-06-04
- Container
- Journal of Analytical Oncology
- Publisher
- Neoplasia Research
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.30683/1927-7229.2026.15.06,
title = {Initial Evaluation of Dihydroartemisinin (DHA), Metformin and Taro Extract in Combination with Cisplatin for Enhanced Cytotoxicity in Triple-Negative Breast Cancer (TNBC) Cell Lines},
author = {Ada Morgan Godwin and Na’Turie Ward and Christopher Krauss and Hirendranath Banerjee and Gloria Payne and Dolapo Adedeji},
year = {2026},
journal = {Journal of Analytical Oncology},
doi = {10.30683/1927-7229.2026.15.06},
url = {https://doi.org/10.30683/1927-7229.2026.15.06}
}RIS
TY - JOUR TI - Initial Evaluation of Dihydroartemisinin (DHA), Metformin and Taro Extract in Combination with Cisplatin for Enhanced Cytotoxicity in Triple-Negative Breast Cancer (TNBC) Cell Lines AU - Ada Morgan Godwin AU - Na’Turie Ward AU - Christopher Krauss AU - Hirendranath Banerjee AU - Gloria Payne AU - Dolapo Adedeji PY - 2026 JO - Journal of Analytical Oncology DO - 10.30683/1927-7229.2026.15.06 UR - https://doi.org/10.30683/1927-7229.2026.15.06 ER -
APA
Godwin, A. M., Ward, N., Krauss, C., Banerjee, H., Payne, G., & Adedeji, D. (2026). Initial Evaluation of Dihydroartemisinin (DHA), Metformin and Taro Extract in Combination with Cisplatin for Enhanced Cytotoxicity in Triple-Negative Breast Cancer (TNBC) Cell Lines. Journal of Analytical Oncology. https://doi.org/10.30683/1927-7229.2026.15.06
Source records
- crossref · retrieved 2026-09-27T03:14:28.036Z